Breadcrumb Home Machine Learning in Drug Discovery Symposium Agenda Machine Learning in Drug Discovery Symposium Overview Agenda Speakers Organizers Advisory Committee Organizing Committee Workshop Getting here Archive 2024 Overview Speakers Organizers Advisory Comittee Organizing Committee Agenda Workshop 2023 Overview Agenda Organizers Advisory Comittee Organizing Committee 2022 Organizers Advisory Committee Organizing Committee Day 1, November 6, 2025 12:00 - 5:00 pm Workshop Day 2, November 7, 2025 8:00 - 6:00 pm Symposium 8:00 - 9:00 am Registration and Breakfast Opening Session 9:00 - 9:10 am Welcome Sumaiya Iqbal Ó³»´«Ã½ 9:10 - 9:25 am Opening Remarks and Keynote Introduction Stacey Gabriel Ó³»´«Ã½ Keynote 9:30 - 10:30 am Keynote From Models to Medicines: Delivering on the Promise of AI-Driven Drug Discovery Thomas Miller Iambic Therapeutics Morning Session Chair: Sumaiya Iqbal 10:30 - 11:10 am Foundation models in biomedicine: from modeling the tissue to modeling all of biology. Bioptimus 11:10 - 11:30 am Break and Poster Viewing 11:30 - 12:10 pm Integrating Physics-Based Simulations and AI to Drug Challenging Targets from the TNF Superfamily and Beyond Psivant Therapeutics 12:10 - 12:30 pm Lightning Talks F.A.D.E. (Fully Agentic Drug Engine): A Conversational AI Platform for Drug Discovery Xue Zong Georgia Institute of Technology PostaNet: Ai-based Framework for Protein Stability Prediction with Experimental Validation Tianjian Liang University of Pittsburgh Genomic Language Models Decipher the Regulatory Code of Splicing for Drug Sensitivity Xueyang He University of Rochester ATLAS Breaks Data Scaling Barriers for MachineLearning via High-Throughput Synthesis and Screening Imran Haque Kimia Therapeutics 12:30 - 2:00 pm Lunch and Poster Viewing Afternoon Session Chair: Wengong Jin 2:00 - 2:40 pm Charting the dark chemical universe with deep learning in low-data scenarios Eindhoven University of Technology 2:40 - 3:00 pm Empowering Biomedical Discovery with "AI Scientists" Harvard Medical School Ó³»´«Ã½ 3:00 - 3:10 pm Awards and Certificates. Moderator: Sumaiya Iqbal AFFIL 3:10 - 3:30 pm Break and Poster Viewing 3:30 - 3:50 pm Foundation Models for Early Drug Discovery Recursion 3:50 - 4:10 pm Modeling and targeting cell states in cancer Microsoft Research 4:10 - 4:30 pm Designing inhibitors of fibroblast activation protein (FAP) using REINVENT AstraZeneca 4:30 - 4:45 pm Closing Remarks and Acknowledgement AFFIL 4:45 - 6:00 pm Reception and poster session Latest news News 11.24.2025 New AI model could speed rare disease diagnosis News 11.20.2025 FDA approves first cancer drug based on Ó³»´«Ã½ science News 11.20.2025 Q&A: How an academic-industry alliance is reshaping the way research can lead to new medicines News 11.19.2025 Single prime editing system could potentially treat multiple genetic diseases All news
News 11.20.2025 Q&A: How an academic-industry alliance is reshaping the way research can lead to new medicines